STERIS plc announced that Esther M. Alegria, Ph.D. has been elected to the Board of Directors, effective May 3, 2023. Dr. Alegria is the Founder and Chief Executive Officer of APIE Therapeutics, where she leads a team focused on the development of therapeutic drugs to treat chronic and debilitating diseases. Prior to APIE, Dr. Alegria was President and Senior Executive Advisor at Catalyst Excel & Advance, an advisory firm providing operational guidance to senior executives working to launch new pharmaceutical and biopharmaceutical companies.

Prior to Catalyst, Dr. Alegria held positions of increasing responsibility at Biogen Inc., most recently as Senior Vice President, Global Manufacturing. Dr. Alegria holds a Ph.D. in chemistry from the University of Hawaii and an executive business management certification from Harvard Business School. She also serves on the Board of Avid Bioservices, Inc, and is a member of its Audit and Corporate Governance Committees.